Latest filing published 06 Nov 2025 for Neurocrine Biosciences INC, €751k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William H. Rastetter is a declared insider at 4 companies (board member); the most frequent names are Neurocrine Biosciences Inc, Fate Therapeutics Inc and Regulus Therapeutics Inc. Between 31 December 2015 and 5 November 2025, the trades on record add up to 13 filings.
The open-market record consists of 1 sale worth €1.9M, with no purchase. The rest of the record consists of 4 share grants and 7 option exercises.
The latest filing, published on 6 November 2025, reports an option exercise of €751k in Neurocrine Biosciences Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations